LivaNova (LIVN) Stock Forecast, Price Target & Predictions
LIVN Stock Forecast
LivaNova stock forecast is as follows: an average price target of $70.50 (represents a 35.32% upside from LIVN’s last price of $52.10) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
LIVN Price Target
The average price target for LivaNova (LIVN) is $70.50 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $88.00 to $62.00. This represents a potential 35.32% upside from LIVN's last price of $52.10.
LIVN Analyst Ratings
According to 4 Wall Street analysts, LivaNova's rating consensus is 'Buy'. The analyst rating breakdown for LIVN stock is 0 'Strong Buy' (0.00%), 3 'Buy' (75.00%), 1 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
LivaNova Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 31, 2024 | Anthony Petrone | Mizuho Securities | $70.00 | $51.05 | 37.12% | 34.36% |
| Oct 04, 2024 | David Roman | Goldman Sachs | $65.00 | $53.90 | 20.59% | 24.76% |
| Sep 17, 2024 | David Rescott | Robert W. Baird | $66.00 | $48.79 | 35.27% | 26.68% |
| Jul 25, 2024 | Rick Wise | Stifel Nicolaus | $72.00 | $53.45 | 34.71% | 38.20% |
| Jun 06, 2024 | Rick Wise | Stifel Nicolaus | $70.00 | $53.16 | 31.68% | 34.36% |
| Mar 20, 2024 | Rick Wise | Stifel Nicolaus | $65.00 | $56.63 | 14.78% | 24.76% |
| Dec 21, 2022 | - | Barclays | $62.00 | $56.05 | 10.62% | 19.00% |
| Nov 23, 2022 | - | Goldman Sachs | $63.00 | $53.95 | 16.77% | 20.92% |
| Aug 16, 2022 | - | Goldman Sachs | $73.00 | $63.86 | 14.31% | 40.12% |
| Aug 04, 2022 | - | Needham | $88.00 | $62.89 | 39.93% | 68.91% |
The latest LivaNova stock forecast, released on Oct 31, 2024 by Anthony Petrone from Mizuho Securities, set a price target of $70.00, which represents a 37.12% increase from the stock price at the time of the forecast ($51.05), and a 34.36% increase from LIVN last price ($52.10).
LivaNova Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 3 | 6 |
| Avg Price Target | $70.00 | $67.00 | $68.00 |
| Last Closing Price | $52.10 | $52.10 | $52.10 |
| Upside/Downside | 34.36% | 28.60% | 30.52% |
In the current month, the average price target of LivaNova stock is $70.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 34.36% increase as opposed to LivaNova's last price of $52.10. This month's average price target is up 4.48% compared to last quarter, and up 2.94% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Feb 21, 2024 | Needham | Buy | Buy | Hold |
| Feb 20, 2024 | Mizuho Securities | - | Buy | Upgrade |
| Oct 23, 2023 | Needham | Buy | Buy | Hold |
| Dec 21, 2022 | Barclays | - | Equal-Weight | Initialise |
| Nov 23, 2022 | Goldman Sachs | Buy | Buy | Hold |
| Aug 16, 2022 | Goldman Sachs | Buy | Buy | Hold |
| Aug 04, 2022 | Needham | Buy | Buy | Hold |
| Feb 24, 2022 | Needham | Buy | Buy | Hold |
LivaNova's last stock rating was published by Needham on Feb 21, 2024. The company gave LIVN a "Buy" rating, the same as its previous rate.
LivaNova Financial Forecast
LivaNova Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $310.10M | $286.11M | $293.90M | $263.40M | $274.90M | $252.60M | $254.20M | $240.18M | $270.06M | $253.22M | $264.48M | $247.60M | $269.56M | $240.08M | $182.21M | $242.40M | $287.59M | $268.61M |
| Avg Forecast | $359.36M | $352.78M | $355.81M | $327.43M | $342.49M | $332.94M | $338.26M | $309.00M | $323.61M | $300.41M | $304.78M | $278.17M | $287.71M | $271.97M | $265.05M | $243.33M | $262.29M | $246.99M | $249.55M | $231.56M | $267.21M | $246.20M | $244.09M | $232.32M | $268.81M | $218.55M | $169.74M | $244.11M | $295.49M | $273.42M |
| High Forecast | $363.50M | $356.84M | $359.90M | $331.20M | $346.44M | $336.77M | $342.16M | $309.05M | $324.74M | $300.96M | $304.78M | $278.17M | $289.83M | $282.50M | $268.10M | $246.13M | $265.31M | $246.99M | $249.55M | $231.56M | $267.21M | $246.20M | $244.09M | $232.32M | $268.81M | $218.55M | $169.74M | $244.11M | $295.49M | $273.42M |
| Low Forecast | $357.40M | $350.85M | $353.86M | $325.65M | $340.62M | $331.12M | $336.41M | $308.95M | $322.64M | $299.85M | $304.78M | $278.17M | $285.86M | $267.18M | $263.60M | $242.00M | $260.85M | $246.99M | $249.55M | $231.56M | $267.21M | $246.20M | $244.09M | $232.32M | $268.81M | $218.55M | $169.74M | $244.11M | $295.49M | $273.42M |
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 5 | 4 | 1 | 1 | 3 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 1.05% | 1.11% | 1.08% | 1.05% | 1.02% | 1.02% | 1.04% | 1.01% | 1.03% | 1.08% | 1.07% | 1.00% | 1.10% | 1.07% | 0.99% | 0.97% | 0.98% |
LivaNova's average Quarter revenue forecast for Mar 24 based on 1 analysts is $278.17M, with a low forecast of $278.17M, and a high forecast of $278.17M. LIVN's average Quarter revenue forecast represents a -10.30% decrease compared to the company's last Quarter revenue of $310.10M (Dec 23).
LivaNova EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 5 | 4 | 1 | 1 | 3 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-88.00M | $4.46M | $17.40M | $12.70M | $29.14M | $11.22M | $31.80M | $24.25M | $99.15M | $-26.12M | $-18.28M | $23.44M | $-13.73M | $18.09M | $11.36M | $22.87M | $58.88M | $21.09M |
| Avg Forecast | $-19.03M | $-18.68M | $-18.84M | $-17.34M | $-18.14M | $-17.63M | $-17.91M | $-16.36M | $-17.14M | $-15.91M | $-16.14M | $34.02M | $-15.24M | $-14.40M | $-14.04M | $30.93M | $17.14M | $23.39M | $23.63M | $28.11M | $25.30M | $23.31M | $23.11M | $5.72M | $25.45M | $20.69M | $16.07M | $18.22M | $27.98M | $25.89M |
| High Forecast | $-18.93M | $-18.58M | $-18.74M | $-17.24M | $-18.04M | $-17.53M | $-17.81M | $-16.36M | $-17.08M | $-15.88M | $-16.14M | $40.82M | $-15.14M | $-14.15M | $-13.96M | $37.11M | $20.57M | $23.39M | $23.63M | $33.74M | $25.30M | $23.31M | $23.11M | $6.86M | $25.45M | $20.69M | $16.07M | $21.86M | $27.98M | $25.89M |
| Low Forecast | $-19.25M | $-18.90M | $-19.06M | $-17.54M | $-18.35M | $-17.83M | $-18.12M | $-16.37M | $-17.20M | $-15.94M | $-16.14M | $27.21M | $-15.35M | $-14.96M | $-14.20M | $24.74M | $13.71M | $23.39M | $23.63M | $22.49M | $25.30M | $23.31M | $23.11M | $4.58M | $25.45M | $20.69M | $16.07M | $14.57M | $27.98M | $25.89M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 5.78% | -0.31% | -1.24% | 0.41% | 1.70% | 0.48% | 1.35% | 0.86% | 3.92% | -1.12% | -0.79% | 4.10% | -0.54% | 0.87% | 0.71% | 1.26% | 2.10% | 0.81% |
3 analysts predict LIVN's average Quarter EBITDA for Dec 23 to be $-15.24M, with a high of $-15.14M and a low of $-15.35M. This is -441.76% lower than LivaNova's previous annual EBITDA (Sep 23) of $4.46M.
LivaNova Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 5 | 4 | 1 | 1 | 3 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $16.30M | $-7.32M | $1.20M | $7.40M | $1.70M | $-107.40M | $16.40M | $2.99M | $-8.53M | $-42.21M | $-55.28M | $-29.66M | $-279.29M | $-14.72M | $-87.95M | $37.58M | $-143.42M | $32.12M |
| Avg Forecast | $58.18M | $55.16M | $57.96M | $49.96M | $51.38M | $49.37M | $54.00M | $43.28M | $43.75M | $39.12M | $42.74M | $3.62M | $42.03M | $34.73M | $29.44M | $3.29M | $-8.52M | $29.79M | $28.21M | $2.99M | $28.19M | $24.33M | $17.92M | $-23.40M | $36.87M | $11.10M | $-16.16M | $46.32M | $53.24M | $40.94M |
| High Forecast | $59.05M | $55.99M | $58.83M | $50.71M | $52.15M | $50.11M | $54.81M | $46.05M | $45.39M | $39.19M | $42.75M | $4.35M | $45.75M | $40.16M | $29.88M | $3.95M | $-6.81M | $29.79M | $28.21M | $3.59M | $28.19M | $24.33M | $17.92M | $-18.72M | $36.87M | $11.10M | $-16.16M | $55.59M | $53.24M | $40.94M |
| Low Forecast | $57.77M | $54.77M | $57.55M | $49.60M | $51.02M | $49.02M | $53.62M | $40.50M | $42.11M | $39.05M | $42.74M | $2.90M | $39.37M | $32.02M | $29.23M | $2.63M | $-10.22M | $29.79M | $28.21M | $2.39M | $28.19M | $24.33M | $17.92M | $-28.08M | $36.87M | $11.10M | $-16.16M | $37.06M | $53.24M | $40.94M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.39% | -0.21% | 0.04% | 2.25% | -0.20% | -3.61% | 0.58% | 1.00% | -0.30% | -1.73% | -3.08% | 1.27% | -7.58% | -1.33% | 5.44% | 0.81% | -2.69% | 0.78% |
LivaNova's average Quarter net income forecast for Mar 24 is $3.62M, with a range of $2.90M to $4.35M. LIVN's average Quarter net income forecast represents a -77.78% decrease compared to the company's last Quarter net income of $16.30M (Dec 23).
LivaNova SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 5 | 4 | 1 | 1 | 3 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $133.30M | $134.79M | $125.90M | $124.10M | $119.60M | $114.63M | $116.50M | $118.53M | $124.43M | $109.04M | $122.75M | $112.62M | $110.35M | $99.20M | $98.05M | $120.18M | $130.61M | $123.02M |
| Avg Forecast | $164.53M | $161.52M | $162.90M | $149.91M | $156.81M | $152.43M | $154.87M | $141.47M | $148.16M | $137.54M | $139.54M | $143.42M | $131.73M | $124.52M | $121.35M | $130.38M | $123.72M | $113.08M | $114.25M | $118.53M | $122.34M | $112.72M | $111.76M | $88.73M | $123.07M | $100.06M | $77.71M | $160.78M | $135.29M | $125.18M |
| High Forecast | $166.42M | $163.38M | $164.78M | $151.64M | $158.61M | $154.19M | $156.65M | $141.49M | $148.68M | $137.79M | $139.54M | $172.10M | $132.70M | $129.34M | $122.75M | $156.45M | $148.46M | $113.08M | $114.25M | $142.23M | $122.34M | $112.72M | $111.76M | $106.48M | $123.07M | $100.06M | $77.71M | $192.94M | $135.29M | $125.18M |
| Low Forecast | $163.63M | $160.64M | $162.01M | $149.09M | $155.95M | $151.60M | $154.02M | $141.45M | $147.72M | $137.28M | $139.54M | $114.73M | $130.88M | $122.33M | $120.69M | $104.30M | $98.97M | $113.08M | $114.25M | $94.82M | $122.34M | $112.72M | $111.76M | $70.98M | $123.07M | $100.06M | $77.71M | $128.62M | $135.29M | $125.18M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.08% | 1.04% | 0.95% | 0.97% | 1.01% | 1.02% | 1.00% | 1.02% | 0.97% | 1.10% | 1.27% | 0.90% | 0.99% | 1.26% | 0.75% | 0.97% | 0.98% |
LivaNova's average Quarter SG&A projection for Mar 24 is $143.42M, based on 1 Wall Street analysts, with a range of $114.73M to $172.10M. The forecast indicates a 7.59% rise compared to LIVN last annual SG&A of $133.30M (Dec 23).
LivaNova EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 5 | 4 | 1 | 1 | 3 | 8 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.30 | $-0.14 | $0.02 | $0.14 | $0.03 | $-2.01 | $0.31 | $0.06 | $-0.16 | $-0.82 | $-1.13 | $-0.61 | $-5.75 | $-0.30 | $-1.81 | $0.78 | $-2.96 | $0.66 |
| Avg Forecast | $1.07 | $1.01 | $1.06 | $0.92 | $0.94 | $0.90 | $0.99 | $0.79 | $0.80 | $0.72 | $0.78 | $0.49 | $0.77 | $0.64 | $0.54 | $0.39 | $0.73 | $0.55 | $0.52 | $0.48 | $0.52 | $0.45 | $0.33 | $0.15 | $0.68 | $0.20 | $-0.30 | $0.43 | $0.98 | $0.75 |
| High Forecast | $1.08 | $1.03 | $1.08 | $0.93 | $0.96 | $0.92 | $1.00 | $0.84 | $0.83 | $0.72 | $0.78 | $0.49 | $0.84 | $0.74 | $0.55 | $0.40 | $0.74 | $0.55 | $0.52 | $0.48 | $0.52 | $0.45 | $0.33 | $0.15 | $0.68 | $0.20 | $-0.30 | $0.43 | $0.98 | $0.75 |
| Low Forecast | $1.06 | $1.00 | $1.05 | $0.91 | $0.93 | $0.90 | $0.98 | $0.74 | $0.77 | $0.72 | $0.78 | $0.49 | $0.72 | $0.59 | $0.54 | $0.39 | $0.73 | $0.55 | $0.52 | $0.48 | $0.52 | $0.45 | $0.33 | $0.15 | $0.68 | $0.20 | $-0.30 | $0.43 | $0.98 | $0.75 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.39% | -0.22% | 0.04% | 0.36% | 0.04% | -3.68% | 0.60% | 0.12% | -0.31% | -1.84% | -3.44% | -3.96% | -8.51% | -1.48% | 6.12% | 1.81% | -3.04% | 0.88% |
According to 1 Wall Street analysts, LivaNova's projected average Quarter EPS for Mar 24 is $0.49, with a low estimate of $0.49 and a high estimate of $0.49. This represents a 62.08% increase compared to LIVN previous annual EPS of $0.30 (Dec 23).
LivaNova Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ATEC | Alphatec | $8.23 | $16.94 | 105.83% | Buy |
| LUNG | Pulmonx | $6.34 | $11.93 | 88.17% | Buy |
| KIDS | OrthoPediatrics | $22.93 | $39.60 | 72.70% | Buy |
| SIBN | SI-BONE | $12.92 | $20.00 | 54.80% | Buy |
| IRTC | iRhythm | $80.45 | $121.17 | 50.62% | Buy |
| BRKR | Bruker | $51.30 | $73.75 | 43.76% | Buy |
| NPCE | NeuroPace | $8.98 | $12.88 | 43.43% | Buy |
| LIVN | LivaNova | $52.10 | $70.50 | 35.32% | Buy |
| CNMD | CONMED | $72.24 | $96.00 | 32.89% | Buy |
| OFIX | Orthofix Medical | $18.08 | $24.00 | 32.74% | - |
| FNA | Paragon 28 | $10.01 | $11.50 | 14.89% | Buy |
| ITGR | Integer | $133.18 | $138.00 | 3.62% | Buy |
| GMED | Globus Medical | $81.10 | $79.54 | -1.92% | Buy |
| GKOS | Glaukos | $138.44 | $123.44 | -10.84% | Buy |